Compounds > flufenamic acid

flufenamic acid and quercetin

flufenamic acid has been researched along with quercetin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izumi, A; Matsumoto, H; Miki, T; Nihro, Y; Satoh, T; Sogawa, S; Ueda, H1
Bruno, RD; Chopra, P; Clement, OO; Gediya, LK; Khandelwal, A; Maheshwari, N; Njar, VC; Purushottamachar, P; Vasaitis, TS1
Cahlikova, L; Chlebek, J; Havrankova, J; Hofman, J; Hostalkova, A; Lundova, T; Musilek, K; Novotna, E; Wsol, V; Zemanova, L1
Atalla, A; Breyer-Pfaff, U; Maser, E1

Other Studies

4 other study(ies) available for flufenamic acid and quercetin

ArticleYear
3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
    Journal of medicinal chemistry, 1993, Nov-26, Volume: 36, Issue:24

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Cell Line; Chalcone; Chalcones; Cyclooxygenase Inhibitors; Edema; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred ICR; Molecular Structure; Sheep; Structure-Activity Relationship

1993
First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.
    Bioorganic & medicinal chemistry, 2007, May-15, Volume: 15, Issue:10

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents; Blotting, Western; Catalysis; Cell Line, Tumor; Computational Biology; Databases, Factual; Dose-Response Relationship, Drug; Down-Regulation; Humans; Male; Models, Molecular; Neoplasm Proteins; Prostatic Neoplasms; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles

2007
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
    Journal of natural products, 2015, Nov-25, Volume: 78, Issue:11

    Topics: Aldehyde Reductase; Aldo-Keto Reductases; Apigenin; Daunorubicin; Enzyme Inhibitors; Flavones; Flavonoids; HCT116 Cells; Humans; Luteolin; Molecular Conformation; Molecular Structure; Neoplasms

2015
Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
    Xenobiotica; the fate of foreign compounds in biological systems, 2000, Volume: 30, Issue:8

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Carcinogens; Cytosol; Enzyme Inhibitors; Female; Flufenamic Acid; Humans; Hydroxysteroid Dehydrogenases; Liver; Male; Medroxyprogesterone Acetate; Middle Aged; NAD; NADP; Nicotiana; Nitrosamines; Phenolphthalein; Plants, Toxic; Quercetin; Rutin; Smoke; Vitamin K

2000